ANI Pharmaceuticals (ANIP) News Today → It’s now possible to know the win rate of every trade… BEFORE you take it! (From WealthPress) (Ad) Free ANIP Stock Alerts $65.36 +0.41 (+0.63%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineANIP ANI Pharmaceuticals, Inc.seekingalpha.com - April 27 at 11:53 AMANI Pharmaceuticals (NASDAQ:ANIP) Given Buy Rating at Guggenheimamericanbankingnews.com - April 24 at 5:16 AMEvaluating ANI Pharmaceuticals: Insights From 5 Financial Analystsmarkets.businessinsider.com - April 23 at 4:37 PMGuggenheim Reaffirms Buy Rating for ANI Pharmaceuticals (NASDAQ:ANIP)marketbeat.com - April 23 at 1:49 PMANI Pharmaceuticals, Inc. (NASDAQ:ANIP) COO Sells $1,095,442.53 in Stockinsidertrades.com - April 23 at 4:22 AMANI Pharmaceuticals, Inc. (NASDAQ:ANIP) COO Muthusamy Shanmugam Sells 16,809 Sharesmarketbeat.com - April 22 at 9:15 PMANI Pharmaceuticals (NASDAQ:ANIP) Updates FY 2024 Earnings Guidanceamericanbankingnews.com - April 22 at 7:20 AMANI Pharmaceuticals (NASDAQ:ANIP) Issues FY 2024 Earnings Guidancemarketbeat.com - April 19 at 5:34 PMMuthusamy Shanmugam Sells 7,414 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stockamericanbankingnews.com - April 19 at 5:22 AMMuthusamy Shanmugam Sells 9,520 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stockamericanbankingnews.com - April 19 at 4:50 AMAni Pharmaceuticals executive sells over $1.5 million in company stockinvesting.com - April 19 at 12:42 AMANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ETglobenewswire.com - April 18 at 4:05 PMANI Pharmaceuticals, Inc. (NASDAQ:ANIP) COO Muthusamy Shanmugam Sells 7,414 Sharesinsidertrades.com - April 18 at 6:31 AMANI Pharmaceuticals, Inc. (NASDAQ:ANIP) VP Sells $16,947.50 in Stockinsidertrades.com - April 16 at 4:46 AMANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is favoured by institutional owners who hold 64% of the companyfinance.yahoo.com - April 12 at 10:41 AMANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Short Interest Down 24.7% in Marchmarketbeat.com - April 12 at 7:37 AMANI Pharmaceuticals (ANIP) Stock Moves -0.13%: What You Should Knowfinance.yahoo.com - April 10 at 10:54 PM3 Biotech Stocks Gaining Altitude and Intereststocknews.com - April 10 at 1:02 PMANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspensionfinanznachrichten.de - April 9 at 10:46 AMANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspensionglobenewswire.com - April 9 at 6:50 AMANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Given Consensus Rating of "Buy" by Brokeragesmarketbeat.com - April 9 at 4:10 AMVanguard Group Inc. Acquires 58,204 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)marketbeat.com - April 8 at 4:08 AMANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosisglobenewswire.com - April 4 at 6:50 AMAssenagon Asset Management S.A. Sells 61,825 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)marketbeat.com - April 4 at 4:39 AMANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Short Interest Updatemarketbeat.com - April 3 at 7:11 AMANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposiumglobenewswire.com - April 3 at 6:50 AMChad Gassert Sells 20,000 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stockinsidertrades.com - April 3 at 4:58 AMANI Pharmaceuticals (ANIP) Dips More Than Broader Market: What You Should Knowfinance.yahoo.com - April 2 at 9:53 PMANI Pharmaceuticals, Inc. (NASDAQ:ANIP) SVP Chad Gassert Sells 20,000 Sharesmarketbeat.com - April 2 at 9:27 PMANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USPglobenewswire.com - March 27 at 6:50 AMANI Pharmaceuticals (NASDAQ:ANIP) Sets New 52-Week High at $70.81marketbeat.com - March 25 at 11:15 AMNYCB, Vista Outdoor, Cardlytics, and More Stocks See Action From Activist Investorsfinance.yahoo.com - March 23 at 12:46 AMANI Pharmaceuticals (ANIP) Outpaces Stock Market Gains: What You Should Knowfinance.yahoo.com - March 21 at 10:41 PMANI Pharmaceuticals Incmoney.usnews.com - March 19 at 1:54 AMANI Pharmaceuticals, Inc. (NASDAQ:ANIP) COO Muthusamy Shanmugam Sells 10,093 Sharesinsidertrades.com - March 17 at 7:26 AMShort Interest in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Increases By 16.7%marketbeat.com - March 16 at 6:48 AMANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Given Consensus Recommendation of "Buy" by Brokeragesmarketbeat.com - March 15 at 8:47 AM3 Biotech Stocks to Jumpstart Your Portfolio Gainsstocknews.com - March 14 at 3:01 PMANI Pharmaceuticals SVP & CFO Sold $510K In Company Stockbenzinga.com - March 12 at 3:34 PMANI Pharmaceuticals (NASDAQ:ANIP) Updates FY24 Earnings Guidancemarketbeat.com - March 12 at 8:23 AMInsider Selling: ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) CFO Sells 7,787 Shares of Stockinsidertrades.com - March 12 at 4:45 AMANI Pharmaceuticals, Inc. (NASDAQ:ANIP) CEO Nikhil Lalwani Sells 16,292 Sharesinsidertrades.com - March 11 at 5:48 AMInsider Selling: ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) CEO Sells 28,965 Shares of Stockinsidertrades.com - March 11 at 5:35 AMSchonfeld Strategic Advisors LLC Sells 18,200 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)marketbeat.com - March 9 at 5:42 AMANI Pharmaceuticals Inc CEO Nikhil Lalwani Sells 45,257 Sharesfinance.yahoo.com - March 9 at 1:40 AMHC Wainwright Weighs in on ANI Pharmaceuticals, Inc.'s Q1 2024 Earnings (NASDAQ:ANIP)marketbeat.com - March 7 at 6:55 AMDirector Antonio Pera Sells 7,000 Shares of ANI Pharmaceuticals Inc (ANIP)finance.yahoo.com - March 7 at 12:53 AMExpert Outlook: ANI Pharmaceuticals Through The Eyes Of 4 Analystsmarkets.businessinsider.com - March 6 at 7:53 PMKennedy Capital Management LLC Sells 91,815 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)marketbeat.com - March 6 at 9:29 AMEquities Analysts Offer Predictions for ANI Pharmaceuticals, Inc.'s Q2 2024 Earnings (NASDAQ:ANIP)marketbeat.com - March 6 at 7:47 AM Get ANI Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIP and its competitors with MarketBeat's FREE daily newsletter. Email Address The “Next Bitcoin”? 10 CENT Crypto Set to Explode (Ad)The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 ANIP Media Mentions By Week ANIP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANIP News Sentiment▼0.140.32▲Average Medical News Sentiment ANIP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANIP Articles This Week▼104▲ANIP Articles Average Week Get ANI Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Morphic News Gyre Therapeutics News Ligand Pharmaceuticals News Kura Oncology News Zai Lab News Arcus Biosciences News Verona Pharma News Day One Biopharmaceuticals News Dynavax Technologies News Pacira BioSciences News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANIP) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ANI Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
